Skip to content

YIELD10 BIOSCIENCE, INC.

Delisted

CIK 1121702fmd_09JGP9WGAFYBDX6D41S3AGZN5SAgriculture, Forestry and Fishing · Agricultural Production-CropsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2024, 58 periods

Latest annual · FY2023

Millions
Total revenues
0
Operating income
(14)
Net income
(14)
Free cash flow
(10)

Latest quarter · Q2 FY2024

Millions
Total revenues
0
Operating income
(3)
Net income
(3)
Free cash flow
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
-57.8%
Revenue, 5 yearsFY2018 to FY2023
-35.9%
Net income, 5 yearsFY2018 to FY2023
n/m

YIELD10 BIOSCIENCE, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$60,000$450,000-86.7%10-K 2024-04-01 · proof
Operating income-$14.4 million-$13.5 million10-K 2024-04-01 · proof
Net income-$14.5 million-$13.6 million10-K 2024-04-01 · proof
Cash from operating activities-$10.1 million-$11.4 million10-K 2024-04-01 · proof
Free cash flow-$10.1 million-$11.6 million10-K 2024-04-01 · proof
Total assets$3.9 million$8.1 million-51.7%10-K 2024-04-01 · proof
Total liabilities$6.4 million$3.7 million+73.4%10-K 2024-04-01 · proof
Cash and cash equivalents$1.1 million$2.4 million-54.7%10-K 2024-04-01 · proof
What was YIELD10 BIOSCIENCE, INC.'s revenue in fiscal 2023?
YIELD10 BIOSCIENCE, INC. reported revenue of $60,000 for fiscal 2023 (the year ended Dec 31, 2023), against $450,000 the year before (-86.7%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What was YIELD10 BIOSCIENCE, INC.'s operating income in fiscal 2023?
YIELD10 BIOSCIENCE, INC. reported operating income of -$14.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$13.5 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What was YIELD10 BIOSCIENCE, INC.'s net income in fiscal 2023?
YIELD10 BIOSCIENCE, INC. reported net income of -$14.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$13.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What was YIELD10 BIOSCIENCE, INC.'s cash from operating activities in fiscal 2023?
YIELD10 BIOSCIENCE, INC. reported cash from operating activities of -$10.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$11.4 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What was YIELD10 BIOSCIENCE, INC.'s free cash flow in fiscal 2023?
YIELD10 BIOSCIENCE, INC. reported free cash flow of -$10.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$11.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What are YIELD10 BIOSCIENCE, INC.'s total assets?
As of Dec 31, 2023, YIELD10 BIOSCIENCE, INC. reported total assets of $3.9 million, against $8.1 million a year earlier (-51.7%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What are YIELD10 BIOSCIENCE, INC.'s total liabilities?
As of Dec 31, 2023, YIELD10 BIOSCIENCE, INC. reported total liabilities of $6.4 million, against $3.7 million a year earlier (+73.4%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC
What are YIELD10 BIOSCIENCE, INC.'s cash and cash equivalents?
As of Dec 31, 2023, YIELD10 BIOSCIENCE, INC. reported cash and cash equivalents of $1.1 million, against $2.4 million a year earlier (-54.7%). Source: the 10-K filed with the SEC on Apr 1, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1121702&period_type=annual&limit=5"

Information only, not investment advice.